106 related articles for article (PubMed ID: 36660018)
21. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5.
Fu DN; Wang Y; Yu LJ; Liu MJ; Zhen D
Exp Cell Res; 2021 Apr; 401(2):112519. PubMed ID: 33636159
[TBL] [Abstract][Full Text] [Related]
22. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
Huang Q; Xing S; Peng A; Yu Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR-199a-3p.
Wang X; Zou J; Chen H; Zhang P; Lu Z; You Z; Sun J
IUBMB Life; 2019 Oct; 71(10):1482-1491. PubMed ID: 31169973
[TBL] [Abstract][Full Text] [Related]
24. lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p.
Wang Y; Zhou B; Yan L; Wu J; Xing Z; Zhang S; Xiang F
Exp Ther Med; 2021 Jun; 21(6):645. PubMed ID: 33968176
[TBL] [Abstract][Full Text] [Related]
25. Exosomes-Derived Long Non-Coding RNA HOTAIR Reduces Laryngeal Cancer Radiosensitivity by Regulating microRNA-454-3p/E2F2 Axis.
Cui X; Xiao D; Cui Y; Wang X
Onco Targets Ther; 2019; 12():10827-10839. PubMed ID: 31849488
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p/PBX3 axis.
Yang XL; Hao YJ; Wang B; Gu XL; Wang XX; Sun JF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(3):1278-1287. PubMed ID: 32096159
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-144-3p Represses the Growth and EMT of Thyroid Cancer via the E2F2/TNIK Axis in Cells and Male BALB/c Nude Mice.
Yi D; Zhang D; Zeng Z; Zhang S; Li M; Zhang Y
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35579981
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA NORAD protects against cerebral ischemia/reperfusion injury induced brain damage, cell apoptosis, oxidative stress and inflammation by regulating miR-30a-5p/YWHAG.
Zhou X; Wang Z; Xu B; Ji N; Meng P; Gu L; Li Y
Bioengineered; 2021 Dec; 12(2):9174-9188. PubMed ID: 34709972
[TBL] [Abstract][Full Text] [Related]
29. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
[TBL] [Abstract][Full Text] [Related]
30. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
Huang JW; Luo XY; Li ZH; Lang BP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
[TBL] [Abstract][Full Text] [Related]
32. LncRNA NORAD regulates scar hypertrophy via miRNA-26a mediating the regulation of TGFβR1/2.
Qi J; Wu Y; Zhang H; Liu Y
Adv Clin Exp Med; 2021 Apr; 30(4):395-403. PubMed ID: 33857357
[TBL] [Abstract][Full Text] [Related]
33. High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway.
Zhou K; Ou Q; Wang G; Zhang W; Hao Y; Li W
Cancer Cell Int; 2019; 19():63. PubMed ID: 30930692
[TBL] [Abstract][Full Text] [Related]
34. Erratum to lncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p.
Editorial Office
Transl Cancer Res; 2024 Feb; 13(2):1221-1224. PubMed ID: 38482419
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
[TBL] [Abstract][Full Text] [Related]
36. Erratum: Loss of lncRNA-SNHG7 Promotes the Suppression of Hepatic Stellate Cell Activation via miR-378a-3p and DVL2.
Yu F; Dong P; Mao Y; Zhao B; Huang Z; Zheng J
Mol Ther Nucleic Acids; 2021 Mar; 23():215-216. PubMed ID: 33376628
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.
Li J; Xu X; Wei C; Liu L; Wang T
Int J Clin Exp Pathol; 2020; 13(1):1-13. PubMed ID: 32055266
[TBL] [Abstract][Full Text] [Related]
39. LncRNA NORAD promotes bone marrow stem cell differentiation and proliferation by targeting miR-26a-5p in steroid-induced osteonecrosis of the femoral head.
Fu D; Yang S; Lu J; Lian H; Qin K
Stem Cell Res Ther; 2021 Jan; 12(1):18. PubMed ID: 33413642
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
He H; Wang N; Yi X; Tang C; Wang D
Cell Biosci; 2017; 7():65. PubMed ID: 29214011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
